Friday, Apr 23rd

Last update:05:44:44 AM IST

Recent Posts:
Homearrow News and Events Year 2010 Second Line HIV Drugs Available in Pune, Nagpur, Aurangabad

Second Line HIV Drugs Available in Pune, Nagpur, Aurangabad

Indian Express
01 December 2010
By Anuradha Mascarenhas
Pune, India

AIDS patients in Pune, Nagpur and Aurangabad won’t have to travel all the way to Mumbai’s J J Hospital as second line drugs for HIV will be made available in the cities soon.

At present, B J Medical College and Sassoon General Hospital’s anti–retroviral treatment (ART) centres have a total of 6,423 patients. Of these, approximately 200 patients require second line drugs and 55 people shortlisted for the treatment have to go to Mumbai for the drugs, ART centre officials at Sassoon Hospital said.

However, Dr Dilip Deshmukh, additional director of Maharashtra State AIDS Control Society (MSACS), said they are planning to set up facilities at Pune, Aurangabad and Nagpur for providing second line drugs.

In the state, a total of 88,420 HIV–infected people are taking ART from 52 centres. MSACS – which implements an HIV prevention care, support and treatment programme in the state – is implementing the third phase of the National AIDS Control Programme (NACP III), which calls for a decentralisation and subsequent strengthening of services at the district level.

Deshmukh said this year, three new ART centres and 10 new link ART centres were opened in the districts.

According to Dr D B Kadam, in charge of the ART centre at B J Medical College, 22,321 people have been registered for their share of drugs, of which 6,423 are presently under treatment.

Of these, 3,126 are men, 2,720 are women, 341 are boys below 15 and 223 girls below 15 years.

At the Armed Forces Medical College, 1,028 HIV patients are on ART while 2,590 are on ART at the YCM Hospital.

In India, an estimated 23.9 lakh people were infected with HIV in 2009 at an estimated adult HIV prevalence of 0.31%.

Adult HIV prevalence among men is 0.36%, while it is 0.25% among women.

Disclaimer: The news story on this page is the copyright of the cited publication. This has been reproduced here for visitors to review, comment on and discuss. This is in keeping with the principle of ‘Fair dealing’ or ‘Fair use’. Visitors may click on the publication name, in the news story, to visit the original article as it appears on the publication’s website.




Know Your Rights!

Link to Aarogya

aarogya logo


This is YOUR sites, so if you have suggestions or feedback on how we can improve it for you, please let us know! We do our best to keep up!

Make a Suggestion